ArticleSkeletal radiology2026
Development and evaluation of multimodal ultrasound radiomics models for predicting active inflammation in rheumatoid arthritis.
Article in Skeletal radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- High-Frequency Ultrasound Radiomics Combined with Clinical Features for Detecting OMERACT-Defined Metacarpophalangeal Joint Cartilage Damage in Early Rheumatoid Arthritis.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo develop a multimodal ultrasound radiomics model integrating power Doppler (PD) and superb microvascular imaging (SMI) data, combined with clinical baseline characteristics, and to evaluate its predictive performance for active inflammation in rheumatoid arthritis (RA).
methodsA total of 2,503 PD and 2,503 SMI ultrasound images of metacarpophalangeal and proximal interphalangeal joints were collected from RA patients with active inflammation and non-active controls between December 2022 and March 2024. Single-modality (PD/SMI), multimodal (SMI_PD), and clinical-integrated models were developed. Diagnostic performance was evaluated using receiver operating characteristic (ROC) analysis.
resultsThe area under the curve (AUC) values for PD, SMI, multimodal SMI_PD, and clinical-integrated models were 0.76, 0.75, 0.82, and 0.83, respectively.
conclusionThe multimodal radiomics model demonstrated superior diagnostic performance for RA active inflammation. SMI shows potential as a tool for subclinical inflammation monitoring, while the integration of multimodal ultrasound radiomics with clinical data further enhances clinical utility.
Indexed as
Identifiers
41353520What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.